Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

Antibody therapies constitute a vast global market: currently valued at over $250 billion, the market for antibodies is ...

As startups navigate the growing biotech sector in Wales, here are five biotech companies that are making waves in 2025.

Discover the latest developments in the neuroplastogens field, including Elkedonia’s funding to address neuropsychiatric ...

Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live ...

Discover what makes Paris's biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters ...

Find out about the University of Edinburgh's work to convert our common plastic wast into the wildly used paracetamol.

Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.

To simplify, think of Novo’s drugs as being protected by two locks in Canada. The first is data exclusivity, a governmental rule that prevents anyone from even trying to copy the drug for eight years ...

The advent of “gepants” for migraines Back to Top The role of CGRP in migraines, specifically its involvement in pain and inflammation during migraine attacks, was first hypothesized around 1983 and ...